Pasithea Therapeutics Corp. (KTTAW) Long-Term Deferred Tax (2021 - 2022)

Pasithea Therapeutics has disclosed Long-Term Deferred Tax across 2 years of filings, most recently posting $4.2 million for Q4 2022.

• In Q4 2022, Long-Term Deferred Tax rose 346.29% year-over-year to $4.2 million; the TTM figure through Dec 2022 stood at $4.2 million (up 346.29% YoY), while the FY2022 annual figure was $4.2 million, up 346.29% from the prior year.
• Long-Term Deferred Tax came in at $4.2 million for Q4 2022 at Pasithea Therapeutics, up from $931000.0 in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $4.2 million in Q4 2022 to a low of $931000.0 in Q4 2021.